Enzymotec Ltd. to Participate in the Wedbush Securities California Dreamin' Consumer Conference: The New York Edition

        Print
| Source: Enzymotec Ltd.

MIGDAL HA'EMEQ, Israel, Dec. 2, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today that Dr. Ariel Katz, the Company's President and Chief Executive Officer, will be presenting at the Wedbush Securities California Dreamin' Consumer Conference: The New York Edition to be held on Tuesday, December 10, 2013 in New York, NY.

Enzymotec's presentation is scheduled for Tuesday, December 10, at 10:20 am ET.

The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.enzymotec.com.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-functional lipid ingredients, as well as final products, based on sophisticated processes and technologies.

ICR, LLC
Katie Turner
646-277-1228
-or-
John Mills
310-954-1105